Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › AZN

FARALLON CAPITAL MANAGEMENT, L.L.C. position in AZN

ASTRAZENECA PLC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 574,000 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$108.8M, representing 0.51% of its reported portfolio and ranking #33 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed AZN holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)574.00K sh
Reported value held$108.84M
Portfolio Weight0.51%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s AZN position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in AZN in Q3 2023 at 6,059,553 shares (US$410.4M). Across 6 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 574,000 shares valued at US$108.8M — an increase of 347,501 shares quarter over quarter.. Notable position changes include a 62% trim in Q1 2024 (shares rose 15% over the following quarter), a 65% increase in Q2 2024 (shares were roughly flat over the following quarter), a 153% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.06M $410.35M New
Q4 2023 3.82M $257.57M Reduce
Q1 2024 1.46M $98.90M Reduce
Q2 2024 2.41M $187.93M Add
Q1 2026 226.50K $44.67M New
Q2 2026 574.00K $108.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held AZN?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed AZN holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in AZN?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 574.00K shares of AZN (ASTRAZENECA PLC), valued at $108.84M, representing 0.51% of its reported portfolio and ranking #33.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling AZN?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in AZN.

Which other funds hold AZN?

Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.